Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma (Q40669502)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 1996
edit
Language Label Description Also known as
English
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
scientific article published on May 1996

    Statements

    Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma (English)
    A P Kudelka
    D Tresukosol
    C L Edwards
    R S Freedman
    C Levenback
    P Chantarawiroj
    C Gonzalez de Leon
    E E Kim
    T Madden
    B Wallin
    M Hord
    C Verschraegen
    M Raber
    J J Kavanagh
    1 May 1996
    1552-1557

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit